New chip could pick healthier sperm for IVF
NCT ID NCT03085433
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a microfluidic chip that gently separates healthy, motile sperm from semen without harsh chemicals. Researchers compared it to the standard spinning method in 393 couples undergoing IVF for unexplained infertility. The goal was to see if the chip leads to higher-quality embryos on day 3 of development.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Microfluidic sperm sorting device
- What this could lead to
- If successful, this device could become a standard, gentler way to select sperm for IVF, potentially improving embryo quality and pregnancy chances.
- What could go wrong
- This is a completed trial, but the improvement in embryo quality may not translate into higher live birth rates. The device may not work for all types of male infertility.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EMBRYO QUALITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of California San Francisco
San Francisco, California, 94158, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can 'Abnormal' embryos still lead to healthy pregnancies? a new registry investigates
- Building a biological treasure trove to decode Women's health mysteries
- Can a sperm 'Quality Check' boost IVF success?
- Foam ultrasound for fertility checks: will women find it comfortable?
- A Hormone's hidden power: could progesterone be the key to unexplained infertility?
- A questionnaire to empower fertility patients — a pilot study puts it to the test